Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





AllTest Biotech Showcases Comprehensive Rapid and Immunoassay Diagnostics at MEDICA 2025

By LabMedica International staff writers
Posted on 19 Nov 2025

Hangzhou AllTest Biotech is showcasing its rapid diagnostic kits and immunoassay platforms at MEDICA 2025. More...

At Booth G11 in Hall 1, the company’s exhibit highlights a wide array of pioneering products across key categories.

AllTest’s comprehensive test lines feature state-of-the-art technologies, such lateral flow immunoassays with portable reader options, fluorescence immunoassay devices, dry biochemistry analyzers, and chemiluminescence immunoassay systems.

Newly launched items include a multiplex respiratory antigen rapid test for swift respiratory pathogen detection, a streamlined Drink Check Test, and a one‑step HIV 1.2 Rapid Test that delivers results in 15 minutes. The lineup also introduces tools for stomach health assessment and viral diarrhea diagnosis.

Established products on display include the hCG Pregnancy Rapid Test (compatible with visual and digital reading); the all‑in‑one Home Use Test Series covering UTI, ovulation, and pregnancy; the HBsAg Rapid Test; and an FDA‑approved Multi‑Drug 2–20 Drugs Rapid Test.

Attendees can review how the platforms align with laboratory and point‑of‑care workflows, from rapid antigen screening to automated immunoassay processing. The company’s experts will be available to show how the company's solutions boost diagnostic speed and transform patient care.

Related Links:
Hangzhou AllTest Biotech


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Portable POCT Blood Gas Analyzer
BD100
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers compared Huntington’s disease biomarkers in CSF and blood with clinical assessments and brain imaging to better understand changes before clinical onset (Image Credit: Adobe Stock)

Blood and Spinal Fluid Biomarker May Help Track Early Huntington’s Disease

Huntington’s disease is a genetic disorder caused by a mutation in the HTT gene that progressively affects movement, cognition, behavior, and independence. Although mutation carriers can be identified... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.